microdose tirzepatide dosage Microdosing: The Growing Off-Label Trend You Should Know About Microdosing

Practical considerations and rationale for glucagon-like peptide-1 receptor agonist plus sodium-dependent glucose cotransporter-2 inhibitor combination therapy in type 2 diabetes

Direct Myocardial Effects Although the presence of functional GLP-1 receptors on human ventricular cardiomyocytes remains a matter of debate, preclinical studies suggest potential direct cardioprotective effects

A Real-World Disproportionality Analysis of Tirzepatide-Related Adverse Events Based on the FDA Adverse Event Reporting System (FAERS) Database

The analysis of change in DBP using a fixed-effects model resulted in less of an effect, 1.57 mmHg (95%CI: 1.75 to 1.39) versus 2.45 mmHg for the random effects model

Our attorneys and co-counsel at Davis, Saperstein & Salomon, P.C

Ellen and her team are wonderful